Literature DB >> 32551626

Binding Hotspot and Activation Mechanism of Maltitol and Lactitol toward the Human Sweet Taste Receptor.

Panupong Mahalapbutr1, Vannajan Sanghiran Lee2, Thanyada Rungrotmongkol1,3,4.   

Abstract

Human sweet taste receptor (hSTR) recognizes a wide array of sweeteners, resulting in sweet taste perception. Maltitol and lactitol have been extensively used in place of sucrose due to their capability to prevent dental caries. Herein, several molecular modeling approaches were applied to investigate the structural and energetic properties of these two polyols/hSTR complexes. Triplicate 500 ns molecular dynamics (MD) simulations and molecular mechanics/generalized Born surface area (MM/GBSA)-based free energy calculations revealed that the TAS1R2 monomer is the preferential binding site for maltitol and lactitol rather than the TAS1R3 region. Several polar residues (D142, S144, Y215, D278, E302, R383, and especially N143) were involved in polyols binding through electrostatic attractions and H-bond formations. The molecular complexation process not only induced the stable form of ligands but also stimulated the conformational adaptation of the TAS1R2 monomer to become a close-packed structure through an induced-fit mechanism. Notably, the binding affinity of the maltitol/TAS1R2 complex (ΔGbind of -17.93 ± 1.49 kcal/mol) was significantly higher than that of the lactitol/TAS1R2 system (-8.53 ± 1.78 kcal/mol), in line with the experimental relative sweetness. These findings provide an in-depth understanding of the differences in the sweetness response between maltitol and lactitol, which could be helpful to design novel polyol derivatives with higher sweet taste perception.

Entities:  

Keywords:  TAS1R2/TAS1R3; lactitol; maltitol; molecular dynamics simulation; sweet taste receptor

Year:  2020        PMID: 32551626     DOI: 10.1021/acs.jafc.0c02580

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  7 in total

1.  Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight.

Authors:  Marutpong Detarya; Worachart Lert-Itthiporn; Panupong Mahalapbutr; Methus Klaewkla; Supannika Sorin; Kanlayanee Sawanyawisuth; Atit Silsirivanit; Wunchana Seubwai; Chaisiri Wongkham; Norie Araki; Sopit Wongkham
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

2.  Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling.

Authors:  Panupong Mahalapbutr; Ronnakorn Leechaisit; Anusit Thongnum; Duangjai Todsaporn; Veda Prachayasittikul; Thanyada Rungrotmongkol; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul; Ratchanok Pingaew
Journal:  ACS Omega       Date:  2022-05-18

3.  Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening.

Authors:  Kamonpan Sanachai; Tuanjai Somboon; Patcharin Wilasluck; Peerapon Deetanya; Peter Wolschann; Thierry Langer; Vannajan Sanghiran Lee; Kittikhun Wangkanont; Thanyada Rungrotmongkol; Supot Hannongbua
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

4.  Discovery of JAK2/3 Inhibitors from Quinoxalinone-Containing Compounds.

Authors:  Kamonpan Sanachai; Panupong Mahalapbutr; Lueacha Tabtimmai; Supaphorn Seetaha; Tanakorn Kittikool; Sirilata Yotphan; Kiattawee Choowongkomon; Thanyada Rungrotmongkol
Journal:  ACS Omega       Date:  2022-09-07

5.  Pharmacophore-Based Virtual Screening and Experimental Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases.

Authors:  Kamonpan Sanachai; Panupong Mahalapbutr; Kowit Hengphasatporn; Yasuteru Shigeta; Supaphorn Seetaha; Lueacha Tabtimmai; Thierry Langer; Peter Wolschann; Tanakorn Kittikool; Sirilata Yotphan; Kiattawee Choowongkomon; Thanyada Rungrotmongkol
Journal:  ACS Omega       Date:  2022-09-06

6.  Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists.

Authors:  Methus Klaewkla; Thanapon Charoenwongpaiboon; Panupong Mahalapbutr
Journal:  J Mol Liq       Date:  2021-05-20       Impact factor: 6.165

7.  Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2'-O-Methyltransferase.

Authors:  Panupong Mahalapbutr; Napat Kongtaworn; Thanyada Rungrotmongkol
Journal:  Comput Struct Biotechnol J       Date:  2020-10-01       Impact factor: 7.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.